World Health Organization

Vacancy: Consultant post for the TB/HIV and community engagement unit of Global TB Programme of WHO

TB/HIV and community engagement unit of the World Health Organization (WHO)’s Global TB Programme coordinates the Department’s work on TB/HIV and the delivery of integrated community based TB activities through both national TB programmes and the engagement of non-governmental (NGO) and other civil society organisations (CSO) to integrate TB into their community-based work in HIV, maternal and child health, primary health care and other sectors such as education, agriculture and livelihood development programmes.

Read More →

WHO guidance on integrated care for people who inject drugs

WHO consolidated guidelines: Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs

Read More →

Global WHO consultation meeting on the programmatic management of latent tuberculosis infection

Seoul, Republic of Korea, 27 – 28 April 2016

Read More →

Training courses offered by WHO Collaborating Centers and partners in the European Region

Click here to access a list of training courses on tuberculosis offered by WHO Collaborating Centers and partners in the European Region.

Read More →

From MDGs to SDGs, WHO launches new report

The World Health Organization report presents the latest data and in-depth analysis for the key areas outlined in the health Sustainable Development Goals, including tuberculosis.

Read More →

WHO policy guidance: The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active TB in people living with HIV

The World Health Organization (WHO) has evaluated a new diagnostic test - Alere DetermineTM - a urine lateral flow lipoarabinomannan assay (LF-LAM,) to determine its suitability for use in the screening or diagnosis of tuberculosis disease.

Read More →

WHO recommends use of two alternative line probe assays

06 November 2015 - WHO has approved the use of two alternative line probe assays (LPAs), with the capability to detect TB and rifampicin resistance. This follows the 2008 recommendation by WHO on the use of LPAs for the rapid detection of rifampicin resistance. At that time, the evidence assessed was for the LPA technology, Hain Version 1 assay.

Read More →

WHO launches Global Action Framework for TB Research and creates new team on TB research

A new Global Action Framework for TB Research will foster high-quality national and global TB research needed to end the TB epidemic. A new Research for TB Elimination team, set up in the WHO Global TB Programme, will facilitate the implementation of this new framework and support the promotion of TB research both at global and country levels.

Read More →

WHO multi-country survey reveals widespread public misunderstanding about antibiotic resistance

16 November 2015 ¦ GENEVA As WHO ramps up its fight against antibiotic resistance, a new multi-country survey shows people are confused about this major threat to public health and do not understand how to prevent it from growing.

Read More →

WHO publication: Active tuberculosis drug-safety monitoring and management (aDSM)

The World Health Organization (WHO) has recently released a consensus document after a meeting on the essential elements for monitoring the safety of anti-TB drugs (aDSM) in Geneva in July 2015.

Read More →

Page 11 of 16 · Total posts: 10

←First 10 11 12 Last→